Agfa-Gevaert is a Belgian specialty materials and imaging technology company — producing offset printing plates, digital print solutions, radiology imaging systems, healthcare IT software and specialty films for industrial and security applications. Listed on Euronext Brussels, Agfa is in structural transformation — traditional film-based businesses are declining while digital healthcare IT and specialty printing are growing. The company provides niche exposure to printing industry, healthcare imaging and specialty materials cycles.
Offset Printing Plates: The Core Declining Business
Agfa's Offset Solutions segment produces photopolymer and thermally processed printing plates for commercial offset printing — newspapers, magazines, packaging. Global offset printing volume has been declining structurally as digital media replaces print. However, packaging printing (labels, folding cartons, flexible packaging) remains relatively resilient as e-commerce drives packaging demand. Agfa maintains leadership in specialty plate segments despite volume decline.
Radiology: The Healthcare Imaging Segment
Agfa HealthCare produces direct radiography (DR) systems, computed radiography (CR) and healthcare IT (ORBIS hospital information system, XERO universal viewer). Radiology imaging tracks healthcare capital expenditure and patient volume cycles. The transition from film-based to digital radiography (completed in most developed markets) has been replaced by the transition to AI-enhanced imaging workflows — where Agfa competes with Philips, Siemens and GE HealthCare.
Specialty Films: Industrial & Security
Agfa produces specialty films for industrial non-destructive testing (NDT) radiography (weld inspection, aerospace quality control) and security applications (laminates for identity documents, banknotes). Industrial NDT film follows energy and aerospace MRO investment cycles. Security laminates track government identity document issuance — relatively stable sovereign demand.
Restructuring: Cost Reduction Focus
Agfa has been restructuring continuously — closing film manufacturing facilities, reducing headcount and optimising its portfolio toward higher-growth segments (healthcare IT, inkjet). The restructuring creates periodic charges that obscure underlying earnings improvement. The long-run thesis is a leaner, higher-margin Agfa focused on digital health and specialty applications.
Cycle Performance Summary
| Parameter | Value |
|---|---|
| Exchange | Euronext Brussels |
| Ticker | AGFB.BR |
| Primary Signal | Printing PMI + healthcare capex |
| Buy Threshold | Printing PMI falls + healthcare volumes decline |
| Sell Threshold | Printing recovers + radiology accelerates |
| Offset Plates | Market leader — structural decline managed |
| HealthCare IT | ORBIS + XERO — digital health growth |
| Cycle Return (2020–2022) | +120% |
Track this signal in real time
Signycle Pro monitors Printing PMI + Healthcare Capex and 16 other macro indicators — alerting you when the next cycle turns.
Join the Pro waitlist →